Can your lifestyle choices protect your memory? New findings from the U.S. POINTER trial suggest they can. Join us on Oct 2 to learn how combining key lifestyle strategies could be your best defense against dementia. Register: https://bit.ly/4pHZNle

Can doctor's slow geographic atrophy progression? Retina specialist Dr. Sara Fard has answers. Join our Macular Chat tomorrow (Sept. 24) at 1 p.m. ET. Listen live 🔊 https://bit.ly/46cyZlj

📢 BrightFocus Foundation is proud to welcome Jimmy Liu, PhD, as our new Director of Vision Science Programs! Dr. Liu brings deep expertise in eye disease research and a passion for advancing the next generation of treatments for macular degeneration and glaucoma. Read more: https://bit.ly/4mjop0x

Join us for our Sept 24 Macular Chat featuring Dr. Sara Fard, a retina specialist at Illinois Retina Associates, as she explains the benefits of sustained GA treatment, including slowing the rate of vision loss, protecting retinal tissue & supporting visual function. Details: https://bit.ly/4miH393

Glaucoma affects more than 4 million Americans & can only be diagnosed through a dilated eye exam—yet too many people don’t know they have glaucoma until irreversible vision loss has occurred. Our new "Stop Glaucoma” PSA encourages everyone to protect their sight: https://bit.ly/46q9jQS

Age-related macular degeneration (AMD) affects millions and can only be diagnosed through eye exams. Many don't know they have it until irreversible vision loss has already occurred. Watch our new PSA featuring first-person accounts of vision loss. Join us to #StopAMD: https://bit.ly/4na8QK1

Dr. Keith Hengen is taking a new approach to Alzheimer's research by studying early brain activity patterns during sleep. Join us on Sept 18 at noon ET on Instagram Live for a conversation about his Alzheimer's research + answers to your questions. Read more: https://bit.ly/3Kme46I.

Despite high risk, people with Down Syndrome are excluded from Alzheimer's trials. Inclusive research will increase their life expectancy by 5 years & reduce care costs. Read about the research co-funded by BrightFocus Foundation and published in @alzdemjournals.bsky.social: https://bit.ly/42rTojT

Attention scientists: Join BrightFocus Foundation for #AlzFastTrack—an official pre-meeting for #SfN25. ⌛ Registration closes Sept 15, 2025! Learn from experts in the Alzheimer’s and dementia field, network, and grow your grant writing skills. Register: https://bit.ly/4gcAMtQ

What if vision loss from glaucoma could be restored? Find out today at 1pm ET, when Dr. Lucy Shen of Mass. Eye and Ear breaks down where the science stands on vision restoration. Watch our livestream to learn about the latest advances in optic nerve regeneration and stem cell and gene therapies. ⤵️

A treatment being tested in clinical trials for mild-to-moderate Alzheimer's using personalized, non-invasive brain stimulation shows promise in slowing cognitive decline and preserving daily function. Read about Dr. Giacomo Koch's research: https://bit.ly/41Jr4JG 🧠 🔬

Dr. Roberta Diaz Brinton from the @uazhealthsciences.bsky.social discusses the ReGenBRAIN clinical trial and the potential for harnessing the brain's natural growth processes for the treatment of Alzheimer’s. Learn more & watch our full episode: https://bit.ly/3JQKxSw #Science #Health #Alzheimers

The connection between sugar and age-related macular degeneration is stronger than you might think. Research indicates that high-glycemic foods like soda, candy, white bread, and pasta create inflammatory compounds that can harm your retina. Read more: https://bit.ly/465PeiL.

We're hosting an Instagram Live on Sept 18 at 12 pm ET with Dr. Sharyn Rossi, senior director neuroscience at BrightFocus Foundation & Dr. Keith Hengen of @uwdeptmedicine.bsky.social. We'll cover sleep and brain health, new research & answer your questions live on Instagram. Set your reminder. 🔔

Join us for an update on the HOPE Study, which is testing whether non-invasive 40 Hz light and sound stimulation can slow Alzheimer’s. We’ll explore what the science shows so far and take your questions about this and other non-invasive dementia treatments. Register now: https://bit.ly/3HZvJR0.

📢 #BreakingNews: The FDA has approved an at-home version of Leqembi, the first anti-amyloid therapy individuals can self-administer with a weekly injection. This new option makes treatment more convenient for families & continues to target harmful brain plaques that drive Alzheimer’s. Read more. ⤵️

A next-generation blood test could personalize Alzheimer's treatment by revealing disease progression—not just diagnosis. BrightFocus Foundation grant recipient, Dr. Gemma Salvadó, helped validate this test to identify ideal candidates for anti-amyloid therapies. 🔬 Full story ⬇️

Join us live TODAY at 1 p.m. ET for a conversation with BrightFocus Foundation Scientific Affairs teammates Dr. Diane Bovenkamp and Dr. Sharyn Rossi as they discuss this year's Macular Degeneration Research bold and innovative projects. To tune in, visit: https://bit.ly/4mAxIdG.

Join us for a 1-hour panel discussion with leaders in the fight against Alzheimer's. This conversation is inspired by Taking Care, a documentary following the journey of Seth Rogen and Lauren Miller Rogen as they navigate Lauren's mother's advancing Alzheimer's. Register: https://bit.ly/4lH7bdc

BrightFocus Foundation recently awarded $3.8 million to researchers advancing bold ideas to understand, prevent, and treat macular degeneration worldwide. Join @dianebovenkamp.bsky.social and Sharyn Rossi, PhD as they discuss this year's innovative projects. Live on 8/27 at 1 pm ET: bit.ly/3UBbzj0

BrightFocus Alzheimer’s Disease Research-funded scientists are developing a home-based brain stimulation treatment that targets memory & mood—all without medication. Learn how this bold new approach could improve quality of life for people living with Alzheimer’s & their families: bit.ly/47xlAFp.

Mengya Zhao, PhD, a BrightFocus National Glaucoma Research grant recipient, uses innovative models to study neuronal resilience to glaucoma. Her findings could reveal survival signals in resistant retinal ganglion cells & guide therapies to protect more sensitive ones. Read more: bit.ly/4m3YdaT 🔬

Think it’s just aging? Why dementia is missed for 3.5 years on average ucl.ac.uk/news/2025/ju... via @ucl.ac.uk #Alzheimers #dementia #health #wellness

Dr. Sandeep Moothedath Subrahmanian of Penn State College of Medicine is studying how a “molecular switch” causes a stress response protein, REDD1, to build up and damage retinal cells in early macular degeneration. His goal: to stop the disease before vision is lost. Read more: bit.ly/47jUpxN

From lifestyle changes that protect memory and cutting-edge blood tests to evidence that past lead exposure can impact brain health decades later—major findings at #AAIC2025 are shaping the future of Alzheimer's prevention, diagnosis, and care. Learn more: bit.ly/3HhDLnO

Join Dr. Amy Zhang from the University of Michigan Kellogg Eye Center on Aug 13 at 1pm ET to discover why proactive glaucoma care matters. We'll discuss cutting-edge options like minimally invasive surgery, at-home pressure monitoring, and continuous drug delivery systems. Learn more. ⬇️

Meet our newest grant recipients across Alzheimer’s, macular degeneration & glaucoma research! These exceptional investigators were selected for their potential to bring us closer to cures by pursuing the untried, the unexpected, and the most promising ideas. Explore their research: bit.ly/4mnqZTX

Day 1 at #AAIC25! Medlive's Vandana Gupta, MSc shared our poster outcomes with Brooks Kenny of @brightfocus.bsky.social, Dustin Gad of @cornelluniversity.bsky.social, Erin Beck of SiteRx, Rebecca Elliot & Julie Wood of @aafp.org, & many other #neurology and #AlzheimersCare leaders. 🔗 bit.ly/41iBNdF

Don’t miss this @ismnd.bsky.social webinar on Monday, August 11 at 10 am Eastern! I’ll be moderating discussions on a highly anticipated presentation by Dr. @petetheteapot.bsky.social Pete Williams, who is a fresh FY25 @brightfocus.bsky.social National Glaucoma Research grantee! See you there.

Live from #AAIC25 in Toronto! Our team is connecting with partners, community advocates, and leading Alzheimer's researchers—including many of our funded scientists. Every connection brings us closer to a #MindSightCure. 🧠 🔬 💪

In collaboration with @medliveofficial.bsky.social we're breaking new ground in digital Alzheimer's education & we're excited to share the latest outcomes at #AAIC25 next week. Our poster (#108349) explores the gap between clinician & patient perspectives on anti-amyloid therapies.

Thank you to the the @brightfocus.bsky.social for featuring my research on retinal deposits and their potential association with AMD. 🐸🧪 @dianebovenkamp.bsky.social www.brightfocus.org/news/how-bet...

When it comes to protecting your sight, knowledge is power. Join us for a chat with @uarizona.bsky.social researchers Drs. Brian McKay & Murray Brilliant about the benefits of AREDS2 supplements for macular degeneration & new research into L-DOPA. Register at: www.brightfocus.org/macular/reso...

We're heading to #AAIC25! As part of our commitment to empowering clinicians & patients through digital education, we’re looking forward to insightful conversations on the future of #BrainHealth. 🔗 bit.ly/44NuNYJ @brightfocus.bsky.social @infusioncenter.bsky.social @alzassociation.bsky.social

🧬 💡 Scientists are using optogenetic therapy (gene therapy + light) to restore some functional vision in people with age-related macular degeneration (AMD). Optogenetics is now entering Phase 2 trials for AMD. Learn more. ⤵️

Did you know that intimate partner violence (IPV) significantly increases a woman’s risk of Alzheimer’s disease by causing hidden brain injuries that go undiagnosed and untreated? Learn more in the BrightFocus Foundation's feature story on Dr. Cheryl Wellington's research.

Excited to be a part of discoveries leading to early diagnostics when treatments are most effective! Dr. Mark Ebbert and his team are making strides in the fight to end Alzheimer's! @ukresearch.bsky.social

What if we could detect Alzheimer’s before it steals memories? BrightFocus Alzheimer’s Disease Research grant recipient Dr. Mark Ebbert of @uksbcoa.bsky.social is using powerful new technology to reveal subtle molecular changes that may lead to an early diagnostic test. Read more. ⤵️

The Trump administration’s proposed 2026 budget would cut NIH funding by 40% and dismantle the agency's 27 specialized institutes and centers, eroding decades of focused expertise and weakening how medical research is conducted. The impact would be staggering. Learn more: BrightFocus.org/NIHCuts

I'm extremely happy to share that I've been awarded the @brightfocus.bsky.social Postdoctoral Grant! 🎉🙌 Huge thanks to BFF for their trust, and heartfelt gratitude to my mentors @marcsuarezcalvet.bsky.social and @bettytijms.bsky.social for their trust and help every step of the way! 💪✨

🎉 Great news!! Dr. @fanastasi.bsky.social has been awarded a prestigious research grant from the @brightfocus.bsky.social‬ to advance personalized approaches to #Alzheimer’s disease. Her project is one of 50 selected globally this year⤵️ www.barcelonabeta.org/en/news/news...

The Senate passed the #OBBB act, threatening healthcare for millions of Americans with Alzheimer's, AMD, and glaucoma. This bill cuts Medicaid/Medicare, limits clinical trials, shifts costs to patients, and reduces specialist access. Learn more: bit.ly/4kiWs82

🚨 Big news! 🚨 Our 2024 Impact Factor is 17.5 🎉 We're now ranked #4 out of 314 neuroscience journals and proudly remain the #1 open-access, peer-reviewed journal in neuroscience 🧠✨ A huge thank you to our editors, authors, @brightfocus.bsky.social and readers for their support!

The ISER/BrightFocus Glaucoma Symposium in Atlanta invites you to contribute to the future of glaucoma research. The abstract submission portal is now open, offering a platform to present your latest findings. Submit your abstract by May 26th iserbrightfocusglaucoma.org/abstract-sub...

Dive deep into glaucoma research at the #BrightFocus #Glaucoma Fast Track, held Oct 8th in conjunction with the @iser.bsky.social ISER/BrightFocus Symposium. This intensive program offers valuable insights & connections for those new to the field. iserbrightfocusglaucoma.org/fast-track/

Hello Vision Science Peeps! Be sure to put the @iser.bsky.social / @brightfocus.bsky.social Concepts and Breakthroughs In Glaucoma Meeting on your schedule. It will be in Atlanta, Georgia, USA from October 8-11, 2025 iserbrightfocusglaucoma.org